Nihon Kohden Co. (OTCMKTS:NHNKY - Get Free Report) shares shot up 13.9% during mid-day trading on Wednesday . The company traded as high as $12.55 and last traded at $12.44. 5,216 shares traded hands during trading, a decline of 7% from the average session volume of 5,616 shares. The stock had previously closed at $10.92.
Nihon Kohden Stock Up 1.6%
The stock has a market cap of $2.07 billion, a price-to-earnings ratio of 17.82 and a beta of 0.32. The business has a 50-day moving average of $13.23 and a 200-day moving average of $14.00.
Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported $0.18 earnings per share for the quarter. Nihon Kohden had a return on equity of 15.08% and a net margin of 7.71%.
Nihon Kohden Company Profile
(
Get Free Report)
Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.
Featured Articles
Before you consider Nihon Kohden, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nihon Kohden wasn't on the list.
While Nihon Kohden currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
